ArticleFrontiers in oncology2025

Patient-derived cell lines unveil COL1A2 as a predictor of docetaxel resistance in breast cancer.

Yuwei Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.